BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11090098)

  • 1. Block of the lymphocyte K(+) channel mKv1.3 by the phenylalkylamine verapamil: kinetic aspects of block and disruption of accumulation of block by a single point mutation.
    Röbe RJ; Grissmer S
    Br J Pharmacol; 2000 Dec; 131(7):1275-84. PubMed ID: 11090098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for an internal phenylalkylamine action on the voltage-gated potassium channel Kv1.3.
    Rauer H; Grissmer S
    Mol Pharmacol; 1996 Dec; 50(6):1625-34. PubMed ID: 8967986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of deep pore mutations on the action of phenylalkylamines on the Kv1.3 potassium channel.
    Rauer H; Grissmer S
    Br J Pharmacol; 1999 Jul; 127(5):1065-74. PubMed ID: 10455250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of verapamil block of a neuronal delayed rectifier K channel: active form of the blocker and location of its binding domain.
    Catacuzzeno L; Trequattrini C; Petris A; Franciolini F
    Br J Pharmacol; 1999 Apr; 126(8):1699-706. PubMed ID: 10372811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of K+ channel block by verapamil and related compounds in rat alveolar epithelial cells.
    DeCoursey TE
    J Gen Physiol; 1995 Oct; 106(4):745-79. PubMed ID: 8576705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic Aspects of Verapamil Binding (On-Rate) on Wild-Type and Six hKv1.3 Mutant Channels.
    Diesch AK; Grissmer S
    Cell Physiol Biochem; 2017; 44(1):172-184. PubMed ID: 29131061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State-dependent verapamil block of the cloned human Ca(v)3.1 T-type Ca(2+) channel.
    Freeze BS; McNulty MM; Hanck DA
    Mol Pharmacol; 2006 Aug; 70(2):718-26. PubMed ID: 16699084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct effects of mutations in transmembrane segment IVS6 on block of L-type calcium channels by structurally similar phenylalkylamines.
    Johnson BD; Hockerman GH; Scheuer T; Catterall WA
    Mol Pharmacol; 1996 Nov; 50(5):1388-400. PubMed ID: 8913371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydropyridine Ca2+ channel antagonists and agonists block Kv4.2, Kv4.3 and Kv1.4 K+ channels expressed in HEK293 cells.
    Hatano N; Ohya S; Muraki K; Giles W; Imaizumi Y
    Br J Pharmacol; 2003 Jun; 139(3):533-44. PubMed ID: 12788813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of K+ and Rb+ on the action of verapamil on a voltage-gated K+ channel, hKv1.3: implications for a second open state?
    Kuras Z; Grissmer S
    Br J Pharmacol; 2009 Jul; 157(5):757-68. PubMed ID: 19371328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the phenylalkylamine binding site in hKv1.3 (H399T), a mutant with a reduced C-type inactivated state.
    Dreker T; Grissmer S
    Mol Pharmacol; 2005 Oct; 68(4):966-73. PubMed ID: 16000530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2.
    Jäger H; Grissmer S
    Toxicon; 2004 Jun; 43(8):951-60. PubMed ID: 15208028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in outward K(+) currents on removal of external Ca(2+) in human atrial myocytes.
    Bertaso F; Hendry BM; Donohoe P; James AF
    Biochem Biophys Res Commun; 2000 Jun; 273(1):10-6. PubMed ID: 10873555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verapamil block of the delayed rectifier K current in chick embryo dorsal root ganglion neurons.
    Trequattrini C; Catacuzzeno L; Petris A; Franciolini F
    Pflugers Arch; 1998 Mar; 435(4):503-10. PubMed ID: 9446697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of potassium channel block in rat alveolar epithelial cells.
    Jacobs ER; DeCoursey TE
    J Pharmacol Exp Ther; 1990 Nov; 255(2):459-72. PubMed ID: 1700814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of verapamil enantiomers and metabolites on cardiac K+ channels expressed in Xenopus oocytes.
    Waldegger S; Niemeyer G; Mörike K; Wagner CA; Suessbrich H; Busch AE; Lang F; Eichelbaum M
    Cell Physiol Biochem; 1999; 9(2):81-9. PubMed ID: 10394001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NH2-terminal inactivation peptide binding to C-type-inactivated Kv channels.
    Kurata HT; Wang Z; Fedida D
    J Gen Physiol; 2004 May; 123(5):505-20. PubMed ID: 15078918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why does the inner-helix mutation A413C double the stoichiometry of Kv1.3 channel block by emopamil but not by verapamil?
    Rossokhin A; Dreker T; Grissmer S; Zhorov BS
    Mol Pharmacol; 2011 Apr; 79(4):681-91. PubMed ID: 21220411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tityustoxin-K(alpha) blockade of the voltage-gated potassium channel Kv1.3.
    Rodrigues AR; Arantes EC; Monje F; Stühmer W; Varanda WA
    Br J Pharmacol; 2003 Jul; 139(6):1180-6. PubMed ID: 12871837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of mammalian Shaker-related K+ channels: evidence for non-conducting closed and non-conducting inactivated states.
    Jäger H; Rauer H; Nguyen AN; Aiyar J; Chandy KG; Grissmer S
    J Physiol; 1998 Jan; 506 ( Pt 2)(Pt 2):291-301. PubMed ID: 9490854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.